Genelux Investor Presentation Deck slide image

Genelux Investor Presentation Deck

Integrated R&D and Manufacturing Capabilities For Phase 3 And Launch Large-Scale cGMP Manufacturing Process to Optimize Production Key Takeaways ● ● ● Established and equipped an independent, Company- controlled 7,500+ Sq. Ft. manufacturing facility in San Diego to secure material for pivotal studies and potential commercial supply CGMP material manufactured and released for the ongoing Phase 3 Trial and Newsoara's trials Planned investment to augment internal development capabilities as well as continually improve proprietary manufacturing processes Genelux aims to meet worldwide clinical trial demand and U.S. commercial launch GENELUX Headquarters Westlake Village, CA, USA Research and Development San Diego, CA, USA So De SCIENCE SAN DIEGO ENCE CENTER CENTER fear Science Starts Manufacturing Facility San Diego, CA, USA Facilities and Operations: Based in Southern California 25
View entire presentation